Insider Shareholders with Direct Ownership of Ngm Biopharmaceuticals Inc (NGM)
This section provides a comprehensive overview of the insiders with direct ownership of Ngm Biopharmaceuticals Inc (NGM). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
NGM BIOPHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Column Group L P
Director |
17,581,168 | 11,103,333 | 1,827,025 $0 | 83 |
Sep 02, 2020
Added 1.49%
|
|
Jin Long Chen
Chief Scientific Officer |
437,970 | 435,082 | 972,893 $0 | 23 |
Mar 02, 2023
Added 6.17%
|
|
David J Woodhouse
Chief Executive Officer |
159,854 | 52,025 | 131,822 $0 | 6 |
Jan 16, 2024
Reduced 9.0%
|
|
David V Goeddel
Director |
54,180 | 134,180 | 130,000 $0 | 4 |
Oct 17, 2022
Added 27.78%
|
| 0 | 5,172 | 80,000 $0 | 1 |
Mar 03, 2022
Added 50.0%
|
|
|
Mangini Siobhan Nolan
President and CFO |
76,000 | 0 | 76,000 $0 | 1 |
Mar 02, 2023
Added 50.0%
|
| 0 | 7,000 | 0 $0 | 1 |
Apr 05, 2024
Reduced 100.0%
|
|
|
Hsiao D Lieu
Chief Medical Officer |
63,000 | 37,037 | 0 $0 | 8 |
Apr 05, 2024
Reduced 100.0%
|
| 49,000 | 31,479 | 0 $0 | 3 |
Apr 05, 2024
Reduced 100.0%
|
|
|
Jean Frederic Viret
Chief Financial Officer |
0 | 3,038 | 0 $0 | 1 |
Apr 05, 2024
Reduced 100.0%
|
|
Irene Perlich
Principal Accounting Officer |
0 | 7,309 | 0 $0 | 2 |
Apr 05, 2024
Reduced 100.0%
|
|
Tcg Opportunity Iii Gp, Llc
> 10% Shareholder |
0 | 11,103,333 | 0 $0 | 1 |
N/A
|
|
Column Group Gp, Lp
> 10% Shareholder |
0 | 11,103,333 | 0 $0 | 1 |
N/A
|